Open AccessAyurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial
Author(s) -
Arvind Chopra,
Manjit Saluja,
Girish Tillu,
S Sarmukkaddam,
Anuradha Venugopalan,
G Narsimulu,
Rohini Handa,
Venil N. Sumantran,
Atul Raut,
Lata Bichile,
Kalpana Joshi,
Bhushan Patwardhan
Publication year - 2013
Publication title -
rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.957
H-Index - 173
eISSN - 1462-0332
pISSN - 1462-0324
DOI - 10.1093/rheumatology/kes414
Subject(s) - medicine , celecoxib , osteoarthritis , adverse effect , womac , randomized controlled trial , boswellia serrata , clinical trial , physical therapy , alternative medicine , pathology
To demonstrate clinical equivalence between two standardized Ayurveda (India) formulations (SGCG and SGC), glucosamine and celecoxib (NSAID).